Back to results

Search for another investment

(CTHT)

Buy:

123.80 p

Sell:

120.00 p

Change:

1.00 (0.83%)

Open an account

CT Healthcare Trust (Red) (CTHT)

Investment Trust
Search input

CT Healthcare Trust (Red)

ISIN:

GB00BZCNLL95

Benchmark:

MSCI World/Health Care

Trading on:

London Stock Exchange

Buy:

123.80 p

Sell:

120.00 p

Change:

1.00 (0.83%)

Updated at: 21/10/2026 - 16:38

*Prices delayed by at least 15 minutes

At a glance

At a glance performance and information

Trading update:

Opening price:

120.00 p

Previous close:

122.00 p

Day High / Low:

122.50 p - 118.80 p

52 week High / Low:

152.00 p - 121.00 p

Volume:

66,376.00

Fundamentals:

Market capitalisation:

£ 51,641,172.22

Total assets:

52,749,900

Published NAV:

124.62 p

Premium + / Discount – (%):

-1.30%

Gross gearing:

0.00%

Dividends:

Last dividend:

GBX 2.565 (18/09/2026)

Dividend yield:

3.85%

Next dividend:

N/A (N/A)

Ex-Dividend date:

N/A

Click to see dividend history

Eligibility:

Share Dealing Account

ISA

SIPP

Investing for longer increases the likelihood of positive returns. Over a period of 5 years or more, investments usually give you a higher return compared to cash savings. But investments can go down as well as up in value. So you could get back less than you put in.

Advanced Chart

Dividends

Dividend overview

Last dividend:

GBX 2.565 (18/09/2026)

Dividend yield:

3.85%

Next dividend:

N/A (N/A)

Ex-Dividend date:

N/A

Dividend data

Year End	Amount	Payment Date	Ex-Div Date	Record Date
31-Dec-2026	GBX 2.565	18-Sep-26	27-Aug-26	N/A
	GBX 2.7	29-May-26	07-May-26	N/A
31-Dec-2025	GBX 2.7	12-Sep-25	14-Aug-25	N/A
	GBX 2.52	30-May-25	01-May-25	N/A
31-Dec-2024	GBX 2.52	29-Aug-24	01-Aug-24	N/A
	GBX 2.995	31-May-24	09-May-24	N/A
31-Dec-2023	GBX 2.995	25-Aug-23	27-Jul-23	N/A
	GBX 3.235	05-May-23	16-Mar-23	N/A
31-Dec-2022	GBX 3.235	02-Sep-22	21-Jul-22	N/A
	GBX 3.015	28-Apr-22	17-Mar-22	N/A

Fees & charges

Fees and Charges

Fees and Charges
Charge	Who receives this?	What is it?	Amount
Ongoing Charges:	The fund manager	The annual charge paid to a fund manager to cover the costs of running the fund. It is an estimate based on the actual amount charged in the previous year.	1.83%
Typical transaction cost:	The fund manager	The costs of dealing within a fund, which the Investment Manager must pay to continue managing the assets. This includes where the Manager decides to sell one stock and buy another. The costs will vary from one fund to another based on how often the Investment Manager trades and the costs applied when trading.	0.188%*
Dealing commission:	Scottish Widows	The cost of buying or selling some or all of your investment.	£5.00 (per online trade)

*This is an indication based on the market average. The fund’s actual transaction cost will be shown before you place a trade.

Account charges are not included

Breakdown

FE fundinfo Rating:

2 of 5

Share type:

Income

Dividend frequency:

No dividends

12 month dividend yield:

3.85%

Ex-Dividend date:

N/A

Top 10 Holdings

Top 10 Holdings
Security	Weight
Revolution medicines, inc.	2.50%
Sanofi	2.40%
Astrazeneca plc	2.20%
Guardant health, inc.	1.80%
Thermo fisher scientific inc.	1.80%
Veradermics	1.80%
Cytokinetics inc	1.70%
Genedx	1.60%
Icon ab	1.60%
Abivax	1.50%

Sectors

Sectors
Sector	Weight
Biotechnology/Medical	22.60%
Pharmaceuticals	9.40%
Biotechnology/Medical	7.90%
Healthcare & Medical Products	2.10%
Healthcare & Medical Products	0.50%
Insurance	-0.40%
Healthcare & Medical Products	-0.50%
Financials	-7.20%

World regions

World regions
Country	Weight
United States	87.80%
Europe	12.20%

Important legal information

The Scottish Widows Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales no. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire, HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under registration number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

The information contained on this website and in the tools, data, prices, news, charts, fundamentals and other content made available through it is provided by Communify Europe Limited, unless expressly stated otherwise.

The information is provided for informational purposes only. It does not constitute investment advice, a personal recommendation, investment research, a research recommendation, an invitation or inducement to engage in investment activity, or a recommendation to buy, sell or hold any share, company, fund, investment vehicle or other financial instrument. Communify Europe Limited does not assess the suitability or appropriateness of any investment for any user.

The information is based on sources that Communify Europe Limited considers reliable. However, Communify Europe Limited does not guarantee that the information is accurate, complete, current, uninterrupted, secure or error-free. Prices, quotes and trades may be delayed by at least fifteen minutes unless expressly stated to be provided in real time.

Past performance is not an indicator of future performance. Communify Europe Limited does not guarantee the return of any investment or the performance of any security, company, investment vehicle, index, underlying asset or market. The value of investments may rise or fall, and investors may lose all or part of the amount invested.

To the extent permitted by applicable law, Communify Europe Limited will not be liable for any loss or damage arising from use of the information contained on this website. Nothing in this notice excludes or limits liability for fraud, death or personal injury caused by negligence, breach of the duty to provide services with reasonable care and skill, or any other liability that cannot be excluded or limited under applicable law. Terms and conditions apply.

The data provided on the website by Broadridge is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. Broadridge makes no assurances or warranties, expressed or implied, as to the accuracy, timeliness, fitness for purpose or availability of the mechanisms by which we receive, store and/or distribute the data. Any views and opinions made on this website do not represent those of Broadridge.